These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 33000243

  • 1. A defucosylated anti‑CD44 monoclonal antibody 5‑mG2a‑f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma.
    Takei J, Kaneko MK, Ohishi T, Hosono H, Nakamura T, Yanaka M, Sano M, Asano T, Sayama Y, Kawada M, Harada H, Kato Y.
    Oncol Rep; 2020 Nov; 44(5):1949-1960. PubMed ID: 33000243
    [Abstract] [Full Text] [Related]

  • 2. Anti‑EpCAM monoclonal antibody exerts antitumor activity against oral squamous cell carcinomas.
    Kaneko MK, Ohishi T, Takei J, Sano M, Nakamura T, Hosono H, Yanaka M, Asano T, Sayama Y, Harada H, Kawada M, Kato Y.
    Oncol Rep; 2020 Dec; 44(6):2517-2526. PubMed ID: 33125138
    [Abstract] [Full Text] [Related]

  • 3. Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell Carcinomas.
    Ishikawa K, Suzuki H, Ohishi T, Li G, Tanaka T, Kawada M, Ohkoshi A, Kaneko MK, Katori Y, Kato Y.
    Int J Mol Sci; 2024 Aug 24; 25(17):. PubMed ID: 39273139
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A defucosylated anti-PD-L1 monoclonal antibody 13-mG2a-f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma.
    Takei J, Ohishi T, Kaneko MK, Harada H, Kawada M, Kato Y.
    Biochem Biophys Rep; 2020 Dec 24; 24():100801. PubMed ID: 32923698
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antitumor activities of a defucosylated anti‑EpCAM monoclonal antibody in colorectal carcinoma xenograft models.
    Li G, Suzuki H, Ohishi T, Asano T, Tanaka T, Yanaka M, Nakamura T, Yoshikawa T, Kawada M, Kaneko MK, Kato Y.
    Int J Mol Med; 2023 Feb 24; 51(2):. PubMed ID: 36660940
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Exerted Antitumor Activities in Mouse Xenograft Models of Canine Mammary Gland Tumor.
    Tanaka T, Ohishi T, Saito M, Suzuki H, Kaneko MK, Kawada M, Kato Y.
    Monoclon Antib Immunodiagn Immunother; 2022 Jun 24; 41(3):142-149. PubMed ID: 35666554
    [Abstract] [Full Text] [Related]

  • 12. An anti‑TROP2 monoclonal antibody TrMab‑6 exerts antitumor activity in breast cancer mouse xenograft models.
    Tanaka T, Ohishi T, Asano T, Takei J, Nanamiya R, Hosono H, Sano M, Harada H, Kawada M, Kaneko MK, Kato Y.
    Oncol Rep; 2021 Jul 24; 46(1):. PubMed ID: 34013368
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anti-HER2 Cancer-Specific mAb, H2Mab-250-hG1, Possesses Higher Complement-Dependent Cytotoxicity than Trastuzumab.
    Suzuki H, Ohishi T, Tanaka T, Kaneko MK, Kato Y.
    Int J Mol Sci; 2024 Aug 01; 25(15):. PubMed ID: 39125956
    [Abstract] [Full Text] [Related]

  • 16. Antiglycopeptide Mouse Monoclonal Antibody LpMab-21 Exerts Antitumor Activity Against Human Podoplanin Through Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity.
    Kato Y, Kunita A, Fukayama M, Abe S, Nishioka Y, Uchida H, Tahara H, Yamada S, Yanaka M, Nakamura T, Saidoh N, Yoshida K, Fujii Y, Honma R, Takagi M, Ogasawara S, Murata T, Kaneko MK.
    Monoclon Antib Immunodiagn Immunother; 2017 Feb 01; 36(1):20-24. PubMed ID: 28234556
    [Abstract] [Full Text] [Related]

  • 17. Antitumor Activities in Mouse Xenograft Models of Canine Mammary Gland Tumor by Defucosylated Mouse-Dog Chimeric Anti-Epidermal Growth Factor Receptor Antibody (E134Bf).
    Li G, Suzuki H, Takei J, Asano T, Sano M, Tanaka T, Harada H, Mizuno T, Ohishi T, Kawada M, Kaneko MK, Kato Y.
    Monoclon Antib Immunodiagn Immunother; 2022 Apr 01; 41(2):53-58. PubMed ID: 35471048
    [Abstract] [Full Text] [Related]

  • 18. A Defucosylated Mouse Anti-CD10 Monoclonal Antibody (31-mG2a-f) Exerts Antitumor Activity in a Mouse Xenograft Model of CD10-Overexpressed Tumors.
    Kawabata H, Suzuki H, Ohishi T, Kawada M, Kaneko MK, Kato Y.
    Monoclon Antib Immunodiagn Immunother; 2022 Apr 01; 41(2):59-66. PubMed ID: 35471051
    [Abstract] [Full Text] [Related]

  • 19. Anti-Metastatic Activity of an Anti-EGFR Monoclonal Antibody against Metastatic Colorectal Cancer with KRAS p.G13D Mutation.
    Ohishi T, Kato Y, Kaneko MK, Ohba SI, Inoue H, Harakawa A, Kawada M.
    Int J Mol Sci; 2020 Aug 21; 21(17):. PubMed ID: 32839411
    [Abstract] [Full Text] [Related]

  • 20. A Defucosylated Mouse Anti-CD10 Monoclonal Antibody (31-mG2a-f) Exerts Antitumor Activity in a Mouse Xenograft Model of Renal Cell Cancers.
    Kawabata H, Ohishi T, Suzuki H, Asano T, Kawada M, Suzuki H, Kaneko MK, Kato Y.
    Monoclon Antib Immunodiagn Immunother; 2022 Dec 21; 41(6):320-327. PubMed ID: 35483055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.